Intrinsic Alpha

Centene Corporation

NYSE:CNC

Medical - Healthcare Plans

Healthcare
$63.78 +1.10%

+$0.67 today

Market cap
$31.58B
Beta
1.09
P/E (TTM)
-4.7
EPS (TTM)
-$13.09
52W Low $25.08High $66.55

Volume 7.01M

Average 6.16M

Financial health

Centene Corporation financial health

Start with the overall verdict and the rule-based risk checks for CNC, then work through liquidity, debt, balance-sheet quality, and claims on cash.

Financial health snapshot

Resilient

Debt service and balance sheet cushion look healthy, even if some working-capital ratios deserve context.

Cash and investments cover debt Healthy short-term liquidity Moderate leverage Interest well covered

Cash & Investments

$43.36B

Debt Cushion

$27.25B

Current Ratio

1.1x

Interest Coverage

9.0x

Risk checks

2 of 11 checks flagged

  • Interest coverage

    -8.3×

    Passes when: Operating income is at least 1.5 times interest expense.

  • Tangible equity base

    66.7%

    Passes when: Goodwill and intangibles are below 50% of equity.

  • Positive equity

    Positive

    Passes when: Shareholders’ equity is above zero.

  • Short-term liquidity

    1.1×

    Passes when: Current assets are at least 1 times current liabilities.

  • Near-term debt coverage

    360.8×

    Passes when: Cash and short-term investments cover debt due within 12 months.

  • Manageable net debt

    Net cash

    Passes when: Net debt is below 3 times EBITDA.

  • Debt repayment from cash flow

    1.8 yr

    Passes when: Free cash flow could repay all debt within 5 years.

  • Debt growth versus revenue growth

    -4.2% vs. 10.5%

    Passes when: Over three years, debt growth is no more than 5 percentage points above revenue growth.

  • Altman Z-score trend

    2.76 → 2.78

    Passes when: The Z-score is stable or rising, or stays above 2.99.

  • Stock-based compensation

    1.8%

    Passes when: Stock-based compensation is no more than 20% of operating cash flow.

  • Share dilution

    -3.2% per year

    Passes when: Diluted share count grows no more than 2% per year.

Financial strength scores

How strong are the fundamentals over time?

Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.

Financial strength scores

Piotroski F-Score and Altman Z-Score from the latest reported financials

Piotroski F-Score

Strong

8 / 9

Nine pass/fail tests of profitability, balance-sheet strength, and efficiency. 8–9 is strong, 0–3 is weak.

Altman Z-Score

Safe zone

3.35

Bankruptcy-risk model. Above 2.99 is the safe zone, 1.81–2.99 the grey zone, and below 1.81 the distress zone.

Score history

Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.

Piotroski: 8–9 strong, 4–7 average, 0–3 weak. Altman: above 2.99 safe, 1.81–2.99 grey, below 1.81 distress. Our calculation can differ slightly from the provider's current scores above.

Liquidity

Can it meet short-term obligations?

Check whether cash and current assets cover what falls due within a year without depending on fresh financing.

Cash & Equivalents

$24.15B

Q2 2026

3Y +12.3%1Y +13.6%

Quick Ratio

1.1x

Q2 2026

Current Ratio

1.1x

Q2 2026

Cash Ratio

0.6x

Q2 2026

Working capital

How quickly does cash come back?

Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.

Working capital and cash conversion

Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.

Working capital (Q2 2026)

$5.93B

Current assets − current liabilities

Days sales outstanding

34 d

-10 days vs. prior year

Days inventory outstanding

0 d

+0 days vs. prior year

Days payables outstanding

44 d

+11 days vs. prior year

Cash conversion cycle

-10 d

-22 days vs. prior year

Leverage

How much debt risk sits on the balance sheet?

Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.

Total Debt

$16.11B

Q2 2026

3Y -2.9%1Y -1.6%

Debt/Equity

0.7x

Q2 2026

Debt/Assets

0.2x

Q2 2026

Interest Coverage

9.0x

Q2 2026

Debt service

Can cash flow carry the debt?

Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.

Debt service capacity

Can operating cash flow carry the debt, and how much is due soon?

Net debt

Net cash: $10.95B

Total debt − cash − short-term investments

Net debt / EBITDA

Net cash

Above 3× is elevated

Free cash flow / debt

55.7%

Share of debt one year of FCF could repay

Years to repay debt

1.8 yr

Total debt ÷ free cash flow

Operating cash flow / current liabilities

0.2×

Above 1× funds a year of obligations

Interest coverage

-8.3×

Operating income ÷ interest expense

Debt maturity

Cash and short-term investments cover short-term debt 360.8×.

Due within 12 months$75MDue later$16.03B

Balance sheet as of Q2 2026; cash flows TTM to Q2 2026.

Debt and cash over time

Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.

Balance sheet cushion

How much room is there if conditions weaken?

Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.

Long-Term Investments

$16.30B

Q2 2026

3Y -3.6%1Y -1.8%

Assets

$83.01B

Q2 2026

3Y +0.4%1Y +2.3%

Liabilities

$60.35B

Q2 2026

3Y -0.4%1Y +1.2%

Balance sheet quality

Who funds the assets, and how tangible is the equity?

Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.

Balance sheet quality

Who funds the assets, and how much of the equity is tangible (Q2 2026).

Claims on $83.01B in assets

  • Payables21.7%
  • Short-term debt0.1%
  • Long-term debt19.3%
  • Deferred revenue0.9%
  • Other liabilities30.8%
  • Equity27.2%

Goodwill + intangibles

$15.04B

18.1% of total assets

Share of equity

66.7%

Above 50% leaves little tangible backing

Tangible equity

$7.52B

Equity left after writing off goodwill and intangibles

Deferred revenue

$706M

Customer prepayments: a liability settled by delivering service, not cash

Shareholder claims

What do shareholders take out of the cash?

Dilution, stock-based pay, dividends, and buybacks all draw on cash flow; check whether free cash flow funds them.

Shareholder claims on cash

Dilution, stock-based pay, and whether free cash flow funds what is returned to shareholders.

Diluted shares, yearly change

-3.2%

Compound annual rate from FY 2020 to FY 2025

Stock-based compensation

$178M

1.8% of operating cash flow

Dividends paid

None

TTM to Q2 2026

Dividend / free cash flow

—

Above 100% means dividends exceed free cash flow

Buybacks

$35M

TTM to Q2 2026

Weighted diluted shares outstanding

Competitor health

How does Centene Corporation compare with peers?

Compare leverage, interest coverage, and liquidity ratios with similar companies.

Competitor Health

Peer financial health comparison

CompanyMarket CapD/ED/AssetsND/EBITDAInt. Cov.QuickCurrentCash

UnitedHealth Group Incorporated

UNH:NYSE

$365.09B0.830.252.344.740.790.790.21

CVS Health Corp.

CVS:NYSE

$114.32B1.240.368.633.330.630.840.10

Elevance Health Inc.

ELV:NYSE

$92.84B0.760.272.465.791.241.240.48

Cigna Corporation

CI:NYSE

$78.26B0.750.202.026.610.720.850.14

Humana Inc.

HUM:NYSE

$54.05B0.730.273.002.300.720.720.41

Molina Healthcare, Inc.

MOH:NYSE

$10.94B0.970.25Net cash4.071.691.690.58

Oscar Health, Inc.

OSCR:NYSE

$8.05B0.440.075.99—0.950.950.57

Alignment Healthcare, Inc.

ALHC:NASDAQ

$1.54B1.890.32Net cash0.931.741.741.21

Questions

Financial health questions

Common questions about CNC's balance sheet, answered from the reported figures.

Is CNC's balance sheet healthy?

Centene Corporation (CNC) has a current ratio of 1.15, a quick read on short-term liquidity.

How leveraged is CNC?

Debt to equity is 0.71, which helps judge how much financing risk sits on the balance sheet.